Anthony D. Martinez MD

Anthony Martinez

Anthony D. Martinez
MD

Clinical Associate Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Addictions; Gastroenterology; HIV Human Immunodeficiency Virus; Illicit Drugs; Infectious Disease; Internal Medicine; Liver (Hepatology); Substance Use; Substance Use Disorder; Translational Research

Contact Information
462 Grider Street
Buffalo, New York 14215
Phone: 716-898-6410
Fax: 716-898-3363
adm35@buffalo.edu
View map


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD

Overview Research Publications Activities Latest News

Professional Summary:

Anthony Martinez, MD, AAHIVS, FAASLD, is an Associate Professor of Medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences with over 20 years of sustained academic contributions across clinical care, scholarship, education, and service. Dr. Martinez is a nationally and internationally recognized leader in viral hepatitis, metabolic liver disease, addiction medicine, and HIV care. His career is distinguished by the creation and leadership of La Bodega, an integrated hepatology–addiction–HIV clinical and research program that has had a measurable impact on patient outcomes, health equity, external funding, and global visibility.
Dr. Martinez is a core faculty member of the GI/Hepatology and Addiction Medicine Fellowship Programs at the University at Buffalo and has developed ACGME-approved curricula in hepatology and addiction medicine. He has provided longitudinal mentorship to fellows, residents, medical students, physician assistants, nurse practitioners, and junior faculty.
Dr. Martinez has an extensive record of institutional, national, and international service. He has held leadership roles within the American Association for the Study of Liver Diseases, including serving on the At-Large Steering Committee for the Hepatitis C Special Interest Group and on the Industry Advancement Committee. He has served as a Special Emphasis Panel Member for the Centers for Disease Control and Prevention and on multiple New York State Department of Health clinical guidelines and advisory committees.
Internationally, he serves on committees for the International Network on Hepatitis in Substance Users and the Chronic Liver Disease Foundation, where he has chaired and co-chaired national committees.
Beyond his home institution, Dr. Martinez is a nationally and internationally invited educator through AASLD, EASL, INHSU, ECHO programs, and CME initiatives.
Martinez, an inductee in the Gold Humanism Honor Society, was honored with a Hepatitis Elimination Champion recognition by the Coalition for Global Hepatitis Elimination in 2024, and he was the 2025 researcher of the year at the University at Buffalo.

Education and Training:
  • Certificate, Infectious Diseases, American Academy of HIV Medicine (2015)
  • Fellowship, Addiction Medicine, Weill Medical College, Cornell University (2007)
  • Fellowship, Hepatitis C Evaluation and Management, Weill Medical College, Cornell University (2007)
  • Internship, Internal Medicine, Boston University, Roger Williams Medical Center (2006)
  • Residency, Internal Medicine, Boston University, Roger Williams Medical Center (2006)
  • MD, Universidad Autonoma de Guadalajara (2002)
  • BS, Biology, Providence College (1998)

Employment:
  • Associate Professor, Hepatology, Erie County Medical Center (2013-present)
  • Associate Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2013-present)
  • Medical Director - Hepatology, GI and Hepatology, Erie County Medical Center (2013-present)
  • Associate Professor, Behavioral Medicine, VA Western NY Healthcare (2013–2017)
  • Associate Clinical Professor of Medicine, University of California San Diego (2012–2013)
  • Attending Physician, University of California (2008–2013)
  • Clinical Assistant Professor of Medicine, University of California San Diego (2008–2012)
  • Clinical Assistant Professor of Medicine and Public Health, Weill Cornell Medical College (2007–2008)
  • Assistant Attending Physician, New York Presbyterian Hospital (2006–2007)
  • Clinical Instructor, Medicine and Public Health, Weill Cornell Medical College (2006–2007)

Awards and Honors:
  • Researcher of The Year (2025)
  • HCV Elimination Champion (2024)
  • New York State World AIDS Day Commissioner's Special Recognition Award (2023)
  • Excellence in Education (2022)
  • Excellence in Healthcare (2022)
  • Gold Humanism Honor Society (2022)
  • America's Top Doctors (2021)
  • Fellow (2020)
  • Nominee, SUNY Hispanic Leadership Institute Fellowship (2020)
  • Siegel Award For Teaching Excellence Nominee (2019)
  • New York State World AIDS Day Commissioner’s Special Recognition Award – Hepatitis C (2018)
  • America's Top Doctors (2017)
  • America's Top Doctors (2016)
  • Award To Clinical Faculty for Scholarship (2016)
  • Junior Resident of the Year (2004)
  • Intern of the Year (2003)
  • National Hispanic Society Scholar (1996)
  • National Kidney Foundation Scholar (1996)
  • Latino Dollars for Scholars Award (1994)

Research Expertise:
  • Addiction Medicine
  • Hepatology
  • HIV specialist
  • Liver disease
  • Medical Marijuana In Clinical Practice
  • Viral Hepatitis

Research Centers:
  • Clinical and Translational Research Center (CTRC)

Grants and Sponsored Research:
  • Gilead Preventative HIV/HCV/HBV Preventative Screening Grant (FOCUS)
    Gilead
    Role: Co-Investigator

Journal Articles:

See all (5 more)

Abstracts:

  • (2025) IMPACT OF FASTING GLUCOSE CONTROL ON CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH METABOLIC DYSFUNCTION AND ALCOHOL RELATED LIVER DISEASE (METALD) AND DIABETES MELLITUS. American Association for the Study of Liver Diseases. Washington, DC, United States (Nov), (1467) Poster
  • (2025) ANTIMICROBIAL THERAPY IN PRIMARY SCLEROSING CHOLANGITIS-INFLAMMATORY BOWEL DISEASE: REAL-WORLD EVIDENCE REVEALS CLINICAL RISKS DESPITE ALKALINE PHOSPHATASE IMPROVEMENT. American Association for the Study of Liver Diseases. Washington, DC, United States (Nov), (4539) Poster
  • (2025) Glecaprevir/pibrentasvir in chronic HCV: an integrated analysis of patients on concomitant opioids, antipsychotics and cardiovascular medications. International Liver Congress, European Association for The Study of Liver. Amsterdam, Netherlands (May) Poster
  • (2024) Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of patients on multiple concomitant medications. American Association for the Study of Liver Diseases. San Diego, CaliforniaUnited States (Nov) Poster
  • (2024) HEPATITIS C MANAGEMENT OF WOMEN IN THE THIRD TRIMESTER OF PREGNANCY IN LA BODEGA. American Association for the Study of Liver Diseases. San Diego, CaliforniaUnited States (Nov) Poster
  • (2024) Same Day and Rapid Start HCV Management in La Bodega Clinic. American Association for the Study of Liver Diseases. San Diego, CaliforniaUnited States (Nov) Oral
  • (2024) Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of patients on multiple concomitant medications. American Association for the Study of Liver Diseases. San Diego, CaliforniaUnited States (Nov) Poster
  • (2024) Statin therapy may protect against variceal bleeding in patients with alcohol-associated liver disease. American Association for the Study of Liver Diseases. San Diego, CaliforniaUnited States (Nov) Poster
  • (2024) Meeting People Where They Are-Street Medicine and Harm Reduction. NACCHO360. Detroit, MichiganUnited States (Aug)
  • (2023) A 10-Year Study of Perinatal Hepatitis B Vaccination Trends in New York State and the Impact of the COVID-19 Pandemic. American Association for the Study of Liver Diseases. Boston, MassachusettsUnited States (Nov)
  • (2023) La Bodega: A Co-Localized Approach to Hepatitis C Management Among People Who Use Drugs. American College of Gastroenterology Annual Meeting. Vancouver, Canada (May), (P4062) Poster
  • (2023) The Hepatology-Addiction-Internal Medicine Co-Localization Model: An Innovative Approach to Achieving Treatment Adherence and Sustained Virologic Response In Psychiatric Patients Infected With Viral Hepatitis. American College of Gastroenterology Annual Meeting. Vancouver, Canada (May) Poster
  • (2023) Cirrhosis Outcomes Are Associate With County Health Disparity In New York State. Digestive Disease Week Annual Meeting. (May), (TU1533) Poster
  • (2023) Giant Cell Hepatitis In a Patient With Adult Onset Type 1 Diabetes Mellitus. American College of Gastroenterology Annual Meeting. United States (Jan), (P2481) Poster
  • Martinez et al. (2022) Hepatitis C virus prevalence and outcomes among pregnant women who inject drugs. 10th International Conference on Health and Hepatitis Care in Substance Users. Glasgow Scottland, (Dec) Poster
  • Martinez, et al. (2022) YOUNGER AGE IS ASSOCIATED WITH LOWER TREATMENT ADHERENCE AMONG PWID TREATED FOR CHRONIC HCV INFECTION. The Liver Meeting American Association For The Study Of Liver Disease. Washington DC, WashingtonUnited States (Nov) Poster
  • Martinez, et al. (2022) ACTIVE DRUG USE IS NOT ASSOCIATED WITH TREATMENT FAILURE AMONG PWID PATIENTS WITH VARIABLE ADHERENCE TO HCV TREATMENT. The Liver Meeting American Association For The Study Of Liver Disease, Washington. Washington, DC, WashingtonUnited States (Nov) Poster
  • Martinez, et al. (2022) 34. VARIABLE ADHERENCE TO HCV TREATMENT AMONG PEOPLE WHO INJECT DRUGS TREATED WITH 8 VERSUS 12 WEEKS OF ANTIVIRAL THERAPY RESULTED IN HIGH RATES OF SVR12 AND REINFECTION RATE WAS LOW. The Liver Meeting American Association For The Study Of Liver Disease. Washington DC, United States (Nov) Poster
  • Martinez, et al. (2022) F3-4 HEPATIC FIBROSIS IS ASSOCIATED WITH BETTER TREATMENT ADHERENCE BUT NOT INCREASED SVR12 AMONG PWID PATIENTS TREATED FOR HCV. The Liver Meeting American Association For The Study Of Liver Disease,. Washington DC, United States (Nov) Poster
  • Martinez, et al. (2022) Reported safety of HCV direct-acting antivirals with opioids: 2017 to 2021. International Liver Congress, European Association for The Study of Liver. London, United Kingdom (May), (2990) Poster
  • (2021) SHORTER DURATION HEPATITIS C VIRUS TREATMENT IS ASSOCIATED WITH BETTER PERSISTENCE TO PRESCRIPTION FILLS IN PEOPLE WHO INJECT DRUGS. American Association For The Study Of Liver Disease, (Nov), (986) Poster
  • (2021) Good Practice Hepatitis C Screening and Linkage To Care Initiatives at the SLTC Summit 2020: Three Out of Four Diagnosed Patients Able To Start Direct-acting Antiviral Treatment. European Association for The Study of Liver, (Apr)
  • Martinez AD. (2015) Age and Risk Factor-Based Serologic Screening for Hepatitis C Virus Among an Urban High-Risk Population. The Liver Meeting, American Association For The Study of Liver Disease, (Nov)
  • Martinez AD. (2015) Utilization of Telemedicine To Treat Hepatitis C at a Medication Assisted Opioid Treatment Program. American Association for the Treatment of Opiate Dependence National Conference, (Jan)
See all (14 more)

Professional Memberships:
  • International Network on Health and Hepatitis in Substance Users (2017–present)
  • American Society for Colposcopy and Cervical Pathology (2015–2016)
  • American Academy of HIV Medicine (2014–present)
  • European Association for the Study of Liver Disease; Member (2012–present)
  • American Association for the Study of Liver Diseases; 2009-Member 2011-Member of AASLD Hepatitis C Special Interest Group (2009–present)
  • American College of Physicians; Member (2008–2012)
  • New York Society of Addiction Medicine; Member (2008–present)
  • USA Boxing, Physician Member (2007–present)
  • New York Medical Reserve Corps; Member (2006–2010)
  • Ameican Society of Addiction Medicine; Member (2006–present)
  • National Hispanic Medical Association; Member (2005–present)
See all (1 more)

Presentations:
  • "Accelerate Action Now: Strategies to Scale-Up Hepatitis Elimination" International Liver Congress, European Association for The Study of Liver (2025)
  • "Hepatitis C Screening and Pre-Treatment Assessment: Point of Care Testing" The New York State Clinical Education Initiative Hepatitis C and Drug User Health Center of Excellence Education Series (2025)
  • "Sabor Y Salud" National LatinX Conference (2025)
  • "Striving Toward Elimination: Advances in Hepatitis C Testing and Treatment" New York State Annual HCV Progress Report Meeting (2025)
  • "Breaking Barriers to HCV Elimination," Global Hepatitis Summit (2025)
  • "La Bodega: A Test and Treat Model for HCV Elimination" INHSU Point-Of-Care Testing Summit (2025)
  • "The Race to 2030: HCV Elimination Progress" National AIDS Treatment Advocacy Project (2025)
  • "Same Day and Rapid Start HCV Management in La Bodega Clinic" Proyecto Cura - La era de la eliminación de la hepatitis C: Estrategias para lograr el acceso a la prevención y atención medica de la hepatitis c para las personas que se inyectan drogas. (2024)
  • "Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of patients on multiple concomitant medications." American Association for the Study of Liver Diseases (2024)
  • "HEPATITIS C MANAGEMENT OF WOMEN IN THE THIRD TRIMESTER OF PREGNANCY IN LA BODEGA" American Association for the Study of Liver Diseases (2024)
  • "Same Day and Rapid Start HCV Management in La Bodega Clinic" American Association for the Study of Liver Diseases (2024)
  • "La Bodega: A Syndemic Approach to HCV Elimination" HIV and HCV Clinical care Symposium for Western NY (2024)
  • "Meeting People Where They Are-Street Medicine and Harm Reduction" NACCHO360 (2024)
  • "Update on HCV Test and Treat Models of Care, Women and Pregnancy" National AIDS Treatment Advocacy Project (2024)
  • "HCV Elimination Update" National LatinX Conference of HIV, HCV and Substance Use Disorder (2024)
  • "A Syndemic Approach to HCV Elimination in the US – La Bodega" Baylor College of Medicine Department of GI, Hepatology and Liver Transplantation Grand Rounds (2024)
  • "Colocalization of HCV and Addiction Services" Scripps 38th Annual New Treatments in Chronic Liver Disease Conference (2024)
  • "La Bodega- Co-Localization of HCV and Addiction Management" Association of Nurses in AIDS Care, (2024)
  • "La Bodega: A Co-Localized Approach to HCV and Addiction Disorders" Tip-HepC webinar: HepC in Pregnancy: Strategies to Improve Linkage to Care and Treatment (2023)
  • "Are We On Track? An Update on the Elimination of HCV" CAHNference (2022)
  • "Co-Medication in People Who Inject Drugs," International Grand Rounds Series (2022)
  • "Headline Views in CLD and GI Disorders: HCV" Chronic Liver Disease Foundation Webcast (2022)
  • "Managing HCV: Tackling Tough Cases" CME Outfitters webcast (2022)
  • "Hepatitis C and People Who Inject Drugs" 50th Annual NAADAC Conference (2022)
  • "Hepatocellular Carcinoma in the Setting of HIV, HCV and HBV" Cancer Prevention for People Living with HIV Continuing Education Course, Erie County Medical Center (2022)
  • "The Syndemic of HCV, HIV and SUD" Division of Addiction Medicine Grand Rounds, University at Buffalo (2022)
  • "HCV For The Rheumatologist" Grand rounds - Division of Rheumatology (2022)
  • "The Syndemic of HIV, HCV and Substance Use" National Latinx Conference on HIV/HCV/SUD (2022)
  • "Treatment Decisions for Patients with HCV and CKD: CMEO Briefcase" CME Outfitters Broadcast (2022)
  • "X-Express: Buprenorphine Prescribing for Beginners Tailored For Gastroenterology and Hepatology Specialists" Clinical Education Initiative affiliated with Mt. Sinai (2022)
  • "HCV/HIV Co-Infection and The Impact of Injection Drug Use" HIV Grand Rounds (2022)
  • "Addressing HCV In Your Patients Struggling With Addiction" The 18th Annual Hepatitis C Summit, Los Angeles, CA (2021)
  • "HCV and Injection Drug Use" Clinical Education Initiative affiliated with Mt. Sinai, NY (2021)
  • "Building momentum towards HCV elimination: re-engaging patients in the COVID-era and beyond" British Columbia Liver Forum (2021)
  • "Decentralized HCV Care: A Perfect Position for Addiction Specialists" National Conference on Addiction Disorders (2021)
  • "HCV Clinical Cases Workshop" British Columbia Liver Forum (2021)
  • "Treating an Evolving Epidemic During the COVID-19 Pandemic" America’s Essential Hospitals Webinar (2021)
  • "Hepatitis C: Why Is It Relevant to Addiction Medicine?," 18th Annual Improving Outcomes In The Treatment Of Opiate Dependence (iOTOD) conference (2021)
  • "HCV Re-Infection" Clinical Education Initiative (2021)
  • "HCV 2021" Western New York Physician Assistant Association (2021)
  • "Medical Marijuana In Clinical Practice" Primary Care Update; University at Buffalo (2017)
  • "Addressing Hepatitis C – Leave No One Behind" United States Conference on AIDS (2016)
  • "HCV - No One Left Behind" 11th National Harm Reduction Conference; National Harm Reduction Organization (2016)
  • "HCV And The Active Substance User" HepCure Webinar; New York State Clinical Education Initiative (2016)
  • "HCV State of The Art" Grand Rounds; University at Buffalo; gastroenterology (2016)
  • "HCV/HIV Co-Infection" Updates In Viral Hepatitis and Hepatocellular Carcinoma Conference; University at Buffalo (2016)
  • "Hepatocellular Carcinoma Screening and Surveillance" Updates In Viral Hepatitis and Hepatocellular Carcinoma Conference; University at Buffalo (2016)
  • "Impact of a Multi-Disciplinary Approach in Disease Management of Hepatic Encephalopathy in Patients with Decompensated Cirrhosis" American College of Gastroenterology Annual Meeting; ACG (2016)
  • "Knowledge of Hepatitis C Acquisition Risks is Associated with Improved Birth Cohort-based Screening Practices among Primary Care Physicians" European Association for The Study of Liver Disease; EASL (2016)
  • "Medical Marijuana: A New Era for Chronic Disease Management in New York State" City Wide Grand Rounds; University at Buffalo (2016)
  • "The Etiology, Natural History and Bleeding Risk of Gastroesophageal Varices" Research Day; University at Buffalo (2016)
  • "Treatment for Hepatitis C: New Tests, New Drugs and New Recommendations" Clinical Education Initiative; Mt. Sinai (2016)
  • "Collaboration In Buffalo: How Liver Care Is Changing The Face of a City" HCV Next Magazine (2015)
  • "Evolving Mindsets: Addiction and Hepatitis C" Association of Nurses in AIDS Care National Meeting; Association of Nurses in AIDS Care (2015)
  • "Treatment for Hepatitis C: New Tests, New Drugs & New Recommendations" The Nurse Practitioner Association of NY State Annual Conference; Nurse Practitioner Association of NY (2015)
  • "Update On The Management of HCV" City Wide Grand Rounds; University at Buffalo (2015)
  • "HCV and Addiction Medicine" Advances in HCV 2015 Conference; University at Buffalo (2015)
  • "HCV and Addiction Medicine" Advances in HCV 2015 Conference; University at Buffalo (2015)
  • "Age and Risk Factor-Based Serologic Screening for Hepatitis C Virus Among an Urban High-Risk Population" The Liver Meeting; American Association for The Study of Liver Disease (2015)
  • "HCV Who is at risk and how can they be reached" Medpage Today interview; University at Buffalo (2015)
  • "Love Your Liver: Clinical Endeavors" Partners in Discovery Lecture Series; University at Buffalo (2015)
  • "Treatment for Hepatitis C: New Tests, New Drugs & New Recommendations" American College of Physicians District Meeting; American College of Physicians (2015)
  • "Utilization of Telemedicine To Treat Hepatitis C at a Medication Assisted Opioid Treatment Program" American Association for the Treatment of Opiate Dependence National Conference (2015)
  • "HCV Management Update" Grand Rounds; University at Buffalo; GI, Hepatology and Nutrition (2014)
  • "It’s Not Chopped Liver! Understanding The Organ and Viral Hepatitis" Mini-Med School Seminar; University at Buffalo; Public (2014)
  • "HCV Management Update" Conference on The Management of Hepatitis C Viral Infection; University at Buffalo; University at Buffalo School of Pharmacy and Biomedical Sciences (2014)
  • "Update On The Management of Hepatitis C Infection" PharmEd Conference (2014)
  • "Implementing Hepatitis C Therapy in a Primary Care Practice" Managing The Hepatitis C Patient: From Screening Through Treatment Conference; SUNY Albany (2014)
  • "Innovations In Treating Hepatitis C" Grand Rounds; Holy Cross Hospital; Medicine (2014)
  • "HCV: A New Era" City Wide Grand Rounds; ; University at Buffalo (2014)
  • "Patient-Centered Evaluation In The HIV/HCV Co-Infected Population" 9th International Conference on HIV Treatment and Prevention Adherence (2014)
  • "HCV Evaluation and Management: The Evolving Paradigm" The New Paradigm of HCV Therapy-Integration of Oral Therapies Into Basic Practices Think Tank; Harvard Medical School (2013)
  • "Viral Hepatitis, Cirrhosis and Liver Cancer: Strategies for Prevention and Control" 2nd Annual UC San Diego Hepatology Program, Clinical Update for The Comprehensive Management of Cirrhosis, Viral Hepatitis, Liver Cancer and End Stage Liver Disease; University of California San Diego (2012)
  • "Advances In The Treatment of HCV" UC San Diego Viral Hepatitis and Hepatocellular Carcinoma Symposium; UC San Diego (2011)
  • "The Integrated Addiction Medicine – Hepatology Model for HCV Management Among Opiate Dependent Individuals on Methadone Maintenance Therapy" Symposium on the Treatment of Hepatitis C Virus in Patients on Opiate Agonist Treatment; Weill Cornell University (2009)
  • "Integration of Treatment Services for Hepatitis C Positive Methadone Patients" International Harm Reduction Association Conference (2008)
  • "Hepatitis C Treatment: An Integrated Approach" American Association for the Treatment of Opiate Dependence National Conference; AATOD (2007)
  • "Model for Translational Medicine in Viral Hepatitis and Substance Abuse Treatment" 18Th International Conference on the Reduction of Drug Related Harm (2007)
  • "Abnormal Liver Function Tests, Viral Hepatitis and MASLD/MASH" Alberta Society of Gastroenterology, Edmonton, Alberta
See all (69 more)

Service Activities:
  • NoHep Medical Visionaries; Mental Health Steering Committee Member (2025–present)
  • Proyecto Cura, Puerto Rico Ends Hep C Program; Advisor (2024–present)
  • Co-Chair Chronic Liver Disease Foundation Viral Hepatitis committee; Co-Chair Chronic Liver Disease Foundation Viral Hepatitis Committee (2024–present)
  • GI division chief search committee; Committee member (2024–present)
  • American Association for The Study of Liver; Industry Advancement Committee Member (2024–present)
  • Hepatitis C Mentor and Support Group; Medical Advisory Member (2024–present)
  • National Hispanic Health Foundation; Physician mentor (2024–present)
  • International Network on Hepatitis in Substance Users; Programming Committee Member (2024–present)
  • GI Division Chief search committee; GI Division Chief search committee (2023–present)
  • Liver Education Advocates; Board Member (2023–present)
  • Committee Member - Appalachian HCV Elimination Summit; Member (2022–present)
  • One-To-One Mentor American Association for the Study of Liver Disease; Mentor (2022–present)
  • Senior Moderator- HCV Special Interest group; Senior Moderator (2022–present)
  • Ambassador - Chronic Liver Disease Foundation; Ambassador (2022–present)
  • ; Committee member - Alliance for Patient Access (2022–present)
  • Faculty Member - International HDV faculty panel; iHEP Hepatitis D (2021–present)
  • New York State Buprenorphine working group; Member (2021–present)
  • New York State Working Group Committee - HCV among People Who Inject Drugs; Member (2021–present)
  • Elected Member At-Large Steering Committee: Hepatitis C Special Interest Group; American Association for the Study of Liver (2020–present)
  • UB HEALS Homeless Outreach program; Faculty mentor (2019–present)
  • Faculty Member international HCV faculty group; iHEP HCV (2019–present)
  • Study to Identify Barriers to HCV Treatment among People Living with HIV (2017–present)
  • Clinical and Translational Science Award Focus Group; Member (2016–present)
  • NYSDOH AIDS Institute Clinical Education Initiative (CEI) ECHO Board; Member (2016–present)
  • University at Buffalo Addiction Initiative – Clinical Services Subcommittee; Member (2016–present)
  • NYSDOH Drug User Health Capacity Building Initiative Advisory Group; Member (2016–present)
  • Western New York PrEP Implementation Working Group; Member (2016–present)
  • Gastroenterology Fellowship Program Evaluation Committee; Member (2015–present)
  • Hpatocellular Carcinoma Service line Collaborative effort with Interventional Radiology, Oncology and Strong Memorial to develop an HCC service line utilizing telemedicine for liver transplant and surgical support. Goal to develop protocols in pathology and radiology to standardize clinical data interpretation; development of a monthly tumor board; development of a tissue bank; development of a HCC CME conference to be held at UB.; Director (2014–present)
  • Faculty and Staff Workforce Diversity committee; Committee Member (2013–present)
  • Member, Expert Panel: New York State Hepatitis C Demonstration Project, Community Health Care Association of New York State; Advisor (2013–present)
  • Faculty and Staff Workforce Diversification committee, a division of the Council of Inclusion in Medicine and Science (CIMS); Member (2013–present)
  • New York State Health Department Hepatitis C Virus Mono-Infection Clinical Guidelines Committee; Member (2013–present)
  • Center for Disease Control; Translating Research to Protect Health through Health Promotion;; Panel Member (2008)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

462 Grider Street
Buffalo, New York 14215
Phone: 716-898-6410
Fax: 716-898-3363
adm35@buffalo.edu
View map

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD
Login to Update Your Profile